Mesa Laboratories (MLAB) Stock Statistics & Valuation Metrics

Mesa Laboratories has a market cap or net worth of $524.21M. The enterprise value is $1.50B.

Mesa Laboratories has 5,455,437 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesa Laboratories’s return on equity (ROE) is -1.75 and return on invested capital (ROIC) is -61.89%.

The current PE Ratio of Mesa Laboratories is -2.37. Mesa Laboratories’s PEG ratio is -18.94.

In the last 12 months, Mesa Laboratories had revenue of 216.19M and earned -254.25M in profits. Earnings per share was -47.20.

In the last 12 months, operating cash flow was 47.03M and capital expenditures -4.03M, giving a free cash flow of 43.00M billion.

Mesa Laboratories pays an annual dividend of $0.16, resulting in a dividend yield of 0.67%

Mesa Laboratories upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.

Mesa Laboratories as a current ratio of 2.47, with Debt / Equity ratio of 43.27%

In the past 12 months, Mesa Laboratories has paid -21.40M in taxes.

Mesa Laboratories EV to EBITDA ratio is -3.38, with an EV/FCF ratio of 19.40.

Mesa Laboratories has $30.96M in cash and marketable securities with $211.61M in debt, giving a net cash position of $180.66M billion.

Gross margin is 61.02%, with operating margin of -125.85%, and net profit margin of -117.60%.

The average price target for Mesa Laboratories is $100.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell